Charalampos Karachalios
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Charalampos Karachalios has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Ilias Liapis
Birmingham Women’s Hospital, Birmingham B15 2TG, West Midlands, UK
4 shared publications - Panagiotis Bakas
Second Department of Obstetrics and Gynecology, Aretaieion Hospital, Medical School, National and Kapodistrian University of Athens, 76, Vasilisis Sofias Avenue, 11528 Athens, Greece
4 shared publications - Evangelos Karamitrousis
Histologistas Research Group, Interinstitutional Postgraduate Program Health and Environmental Factors, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece
3 shared publications Aggelos Liapis
University of Athens
2 shared publications- Angeliki Papadimitriou
Gynecology Clinic, General Hospital of Athens “LAIKO”, 11527 Athens, Greece
2 shared publications - Antonios Lagadas
Gynecology Clinic, General Hospital of Athens “LAIKO”, 11527 Athens, Greece
2 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Springer Nature in The Egyptian Journal of Internal Medicine
- Vol. 38 (1) , 164
What is the impact of oral probiotic supplementation on the HOMA-IR insulin resistance index in pregnant women with gestational diabetes mellitus without antidiabetic medication during the current pregnancy? A systematic review and meta-analysis
Background: Gestational diabetes mellitus (GDM) is a common pregnancy complication, with an estimated global prevalence of up to 14%. While lifestyle and genetic risk factors for GDM are well documented, the effect of probiotic supplementation on the management of GDM-specifically through the reduction of insulin resistance as measured by the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) index-has not been systematically evaluated. Objective: This meta-analysis aimed to quantitatively evaluate the clinical efficacy of probiotic supplementation in reducing the HOMA-IR index in a population of pregnant women with diagnosed GDM who manage the disease without the use of antidiabetic pharmacotherapy (insulin or oral agents), as well as to address the probiotics as an evidence-based, adjunctive therapeutic strategy for a more effective regulation of the metabolic profile during pregnancy. Methods: PubMed, Scopus, and Cochrane databases were searched for original research articles published up to August 10, 2025, which could potentially evaluate the impact of oral probiotic supplementation to the reduction of the HOMA-IR insulin resistance index in pregnant women with GDM without antidiabetic medication during the current pregnancy. A random-effects model was applied to estimate weighted mean differences (MDs) and 95% confidence intervals (CIs). Results: Four randomized controlled trials comprising 245 women (128 in the probiotic group and 126 in the placebo group) were included. The meta-analysis demonstrated a statistically significant reduction in the HOMA-IR levels in the intervention group compared to the control group (weighted MD: -0.51, 95% CI: -0.90 to -0.11, p = 0.01). Significant heterogeneity was observed among the studies (I 2 = 61.3%). Conclusion: The administration of probiotics appears to improve insulin sensitivity in women with GDM and may serve as a useful adjunctive therapy.
- 23 October 2026
- Published by Springer Nature in The Egyptian Journal of Internal Medicine
- Vol. 38 (1) , 164
Open AccessWhat is the impact of oral probiotic supplementation on the HOMA-IR insulin resistance index in pregnant women with gestational diabetes mellitus without antidiabetic medication during the current pregnancy? A systematic review and meta-analysis
Background: Gestational diabetes mellitus (GDM) is a common pregnancy complication, with an estimated global prevalence of up to 14%. While lifestyle and genetic risk factors for GDM are well documented, the effect of probiotic supplementation on the management of GDM-specifically through the reduction of insulin resistance as measured by the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) index-has not been systematically evaluated. Objective: This meta-analysis aimed to quantitatively evaluate the clinical efficacy of probiotic supplementation in reducing the HOMA-IR index in a population of pregnant women with diagnosed GDM who manage the disease without the use of antidiabetic pharmacotherapy (insulin or oral agents), as well as to address the probiotics as an evidence-based, adjunctive therapeutic strategy for a more effective regulation of the metabolic profile during pregnancy. Methods: PubMed, Scopus, and Cochrane databases were searched for original research articles published up to August 10, 2025, which could potentially evaluate the impact of oral probiotic supplementation to the reduction of the HOMA-IR insulin resistance index in pregnant women with GDM without antidiabetic medication during the current pregnancy. A random-effects model was applied to estimate weighted mean differences (MDs) and 95% confidence intervals (CIs). Results: Four randomized controlled trials comprising 245 women (128 in the probiotic group and 126 in the placebo group) were included. The meta-analysis demonstrated a statistically significant reduction in the HOMA-IR levels in the intervention group compared to the control group (weighted MD: -0.51, 95% CI: -0.90 to -0.11, p = 0.01). Significant heterogeneity was observed among the studies (I 2 = 61.3%). Conclusion: The administration of probiotics appears to improve insulin sensitivity in women with GDM and may serve as a useful adjunctive therapy.
- Open Access
- 8 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 497
Investigating the Impact of Antioxidant Supplementation on Male Infertility: A Scoping Review
Infertility affects thousands of couples internationally, leaving a profound effect on their families and communities. According to the World Health Organization (WHO), approximately one out of six individuals of reproductive age worldwide experiences infertility in their life span. Approximately 35% of infertile couples are affected by male factor infertility, in which semen analysis is the gold standard diagnostic procedure. Oxidative stress (OS) is considered to play a pivotal role in the pathogenesis of male infertility. A thorough literature search was conducted in PubMed/MEDLINE, Scopus and Google Scholar databases, using MeSH terms and free-text keywords, to retrieve eligible articles published in the last decade, focusing on the potential beneficial role of oral antioxidants in male infertility. Antioxidant supplementation appears to improve the majority of sperm parameters. Therefore, antioxidant therapy is emerging as a promising aid in addressing male infertility. The purpose of this comprehensive literature review is to evaluate the significance of antioxidant supplementation in improving sperm parameters. Most of the included randomized controlled trials demonstrated the positive effects of oral antioxidants in various parameters, such as sperm concentration, total sperm count, motility and progressive motility. Consequently, pregnancy outcomes were evaluated, and increased pregnancy rates were reported in the majority of the included studies.
- 8 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 497
Open AccessInvestigating the Impact of Antioxidant Supplementation on Male Infertility: A Scoping Review
Infertility affects thousands of couples internationally, leaving a profound effect on their families and communities. According to the World Health Organization (WHO), approximately one out of six individuals of reproductive age worldwide experiences infertility in their life span. Approximately 35% of infertile couples are affected by male factor infertility, in which semen analysis is the gold standard diagnostic procedure. Oxidative stress (OS) is considered to play a pivotal role in the pathogenesis of male infertility. A thorough literature search was conducted in PubMed/MEDLINE, Scopus and Google Scholar databases, using MeSH terms and free-text keywords, to retrieve eligible articles published in the last decade, focusing on the potential beneficial role of oral antioxidants in male infertility. Antioxidant supplementation appears to improve the majority of sperm parameters. Therefore, antioxidant therapy is emerging as a promising aid in addressing male infertility. The purpose of this comprehensive literature review is to evaluate the significance of antioxidant supplementation in improving sperm parameters. Most of the included randomized controlled trials demonstrated the positive effects of oral antioxidants in various parameters, such as sperm concentration, total sperm count, motility and progressive motility. Consequently, pregnancy outcomes were evaluated, and increased pregnancy rates were reported in the majority of the included studies.
- Open Access
- 26 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (17) , 6031
Pregnancy-Related Acute Kidney Injury: Causes and Its Impact on Perinatal Outcomes—A Systematic Review
Background: Pregnancy-Related Acute kidney injury (PRAKI) is a critical complication of pregnancy, defined by the sudden deterioration in renal function during gestation or within the initial six weeks postpartum. Pregnancy is thought to increase the risk of acute kidney injury (AKI) by 51%. This is linked to the anatomical alterations that occur during pregnancy and special conditions, such as preeclampsia/eclampsia. PRAKI’s epidemiology and outcome vary between developed and developing nations. PRAKI is an uncommon entity in high-income countries; however, its incidence has recently increased. The aim of this systematic review is to evaluate the maternal and perinatal outcomes and risk factors affecting pregnancies affected by AKI. Methods: Comprehensive research was performed in PubMed/Medline, Scopus, and Google Scholar electronic databases from 2015 up to January 2025, using the terms AKI, PRAKI, sepsis, preeclampsia/eclampsia, liver enzymes, low platelet count (HELLP) syndrome, and pregnancy. After a thorough assessment, 25 full-text articles were obtained. Results: Our results revealed that preeclampsia, eclampsia, HELLP syndrome, and antepartum and postpartum hemorrhage predispose women to PRAKI. Other unusual factors, like disseminated intravascular coagulation (DIC) or hemolytic uremic syndrome (HUS), should not be underestimated. Furthermore, the latest published data showed unfavorable maternal and fetal outcomes in pregnancies affected by AKI compared to the general population. Conclusions: PRAKI constitutes a serious pregnancy complication that requires immediate treatment. The higher prevalence of PRAKI in developing countries (4–26%) versus wealthy nations (1.0–2.8%) has considerably indicated the impact of socioeconomic status and the accessibility of health services.
- 26 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (17) , 6031
Open AccessPregnancy-Related Acute Kidney Injury: Causes and Its Impact on Perinatal Outcomes—A Systematic Review
Background: Pregnancy-Related Acute kidney injury (PRAKI) is a critical complication of pregnancy, defined by the sudden deterioration in renal function during gestation or within the initial six weeks postpartum. Pregnancy is thought to increase the risk of acute kidney injury (AKI) by 51%. This is linked to the anatomical alterations that occur during pregnancy and special conditions, such as preeclampsia/eclampsia. PRAKI’s epidemiology and outcome vary between developed and developing nations. PRAKI is an uncommon entity in high-income countries; however, its incidence has recently increased. The aim of this systematic review is to evaluate the maternal and perinatal outcomes and risk factors affecting pregnancies affected by AKI. Methods: Comprehensive research was performed in PubMed/Medline, Scopus, and Google Scholar electronic databases from 2015 up to January 2025, using the terms AKI, PRAKI, sepsis, preeclampsia/eclampsia, liver enzymes, low platelet count (HELLP) syndrome, and pregnancy. After a thorough assessment, 25 full-text articles were obtained. Results: Our results revealed that preeclampsia, eclampsia, HELLP syndrome, and antepartum and postpartum hemorrhage predispose women to PRAKI. Other unusual factors, like disseminated intravascular coagulation (DIC) or hemolytic uremic syndrome (HUS), should not be underestimated. Furthermore, the latest published data showed unfavorable maternal and fetal outcomes in pregnancies affected by AKI compared to the general population. Conclusions: PRAKI constitutes a serious pregnancy complication that requires immediate treatment. The higher prevalence of PRAKI in developing countries (4–26%) versus wealthy nations (1.0–2.8%) has considerably indicated the impact of socioeconomic status and the accessibility of health services.
- Open Access
Human Papillomaviruses and Malignant Neoplasms of the Female Upper Reproductive Tract: A Comprehensive Review of the Literature
Malignancies of the female upper reproductive tract, especially endometrial and ovarian cancers, generate a significant burden for women worldwide. The possible etiopathogenetic role of chronic human papillomavirus (HPV) infection in the carcinogenesis of the female upper genital tract is neither clearly established not completely understood. Therefore, we performed a literature review, using the PubMed and SCOPUS electronic databases, of the prevalence of HPV DNA in endometrial, primary fallopian tube, ovarian, and primary peritoneal cancers, as well as uterine sarcomas. The present investigation covered 35 studies from different countries on various continents. Overall, the prevalence of HPV was approximately 15% in all the above cancers. HPV DNA was isolated from 11%, 0%, 0%, and 14% of endometrial carcinomas, uterine sarcomas, primary fallopian tube cancers, and ovarian malignant neoplasms, respectively. No relevant studies on primary peritoneal cancers were retrieved. The predominant HPV strain from tumors of the upper female reproductive tract, regardless of the tumor site, was HPV-16, followed by HPV-18. The HPV DNA identified was exclusively from subtypes HPV-6, HPV-11, HPV-16, HPV-18, and HPV-33, which are responsible for the development of not only cervical cancer, but also condylomata acuminata. The findings of the present review indicate that HPV vaccination might prove to be a useful strategy in the prevention of HPV-related carcinomas of the upper genital tract in women.
Open AccessHuman Papillomaviruses and Malignant Neoplasms of the Female Upper Reproductive Tract: A Comprehensive Review of the Literature
Malignancies of the female upper reproductive tract, especially endometrial and ovarian cancers, generate a significant burden for women worldwide. The possible etiopathogenetic role of chronic human papillomavirus (HPV) infection in the carcinogenesis of the female upper genital tract is neither clearly established not completely understood. Therefore, we performed a literature review, using the PubMed and SCOPUS electronic databases, of the prevalence of HPV DNA in endometrial, primary fallopian tube, ovarian, and primary peritoneal cancers, as well as uterine sarcomas. The present investigation covered 35 studies from different countries on various continents. Overall, the prevalence of HPV was approximately 15% in all the above cancers. HPV DNA was isolated from 11%, 0%, 0%, and 14% of endometrial carcinomas, uterine sarcomas, primary fallopian tube cancers, and ovarian malignant neoplasms, respectively. No relevant studies on primary peritoneal cancers were retrieved. The predominant HPV strain from tumors of the upper female reproductive tract, regardless of the tumor site, was HPV-16, followed by HPV-18. The HPV DNA identified was exclusively from subtypes HPV-6, HPV-11, HPV-16, HPV-18, and HPV-33, which are responsible for the development of not only cervical cancer, but also condylomata acuminata. The findings of the present review indicate that HPV vaccination might prove to be a useful strategy in the prevention of HPV-related carcinomas of the upper genital tract in women.
- Open Access
- 13 May 2025
- Published by MDPI AG in Preprints.org
Human Papillomaviruses and Malignant Neoplasms of the Female Upper Reproductive Tract: A Comprehensive Review of the Literature
Malignancies of the female upper reproductive tract, especially endometrial and ovarian cancers, consist a significant burden for women worldwide. The possible etiopathogenetic role of chronic human papillomavirus (HPV) infection in the female upper genital tract carcinogenesis is neither clearly established not completely understood. Therefore, we performed a literature review through PubMed and SCOPUS electronic databases about the prevalence of HPV DNA in endometrial, primary fallopian tube, ovarian and primary peritoneal cancers, as well as uterine sarcomas. The present investigation covered 35 studies from different countries of various continents. Overall, HPV prevalence was approximately 15% in all the above cancers. HPV DNA was isolated from 11%, 0%, 0% and 14% of endometrial carcinomas, uterine sarcomas, primary fallopian tube cancers and ovarian malignant neoplasms, respectively. No relevant studies on primary peritoneal cancers were retrieved. The predominant HPV strain from all tumors of the upper female reproductive tract, regardless of the tumor site, was mostly HPV-16, followed by HPV-18. HPV DNA was identified exclusively from subtypes HPV-6, HPV-11, HPV-16, HPV-18, and HPV-33, which are responsible for the development of not only cervical cancer, but also of condylomata acuminata. The findings of the present review indicate that HPV vaccination might prove to be a useful strategy in the prevention HPV-related carcinomas of the upper genital tract in women.
- 13 May 2025
- Published by MDPI AG in Preprints.org
Open AccessHuman Papillomaviruses and Malignant Neoplasms of the Female Upper Reproductive Tract: A Comprehensive Review of the Literature
Malignancies of the female upper reproductive tract, especially endometrial and ovarian cancers, consist a significant burden for women worldwide. The possible etiopathogenetic role of chronic human papillomavirus (HPV) infection in the female upper genital tract carcinogenesis is neither clearly established not completely understood. Therefore, we performed a literature review through PubMed and SCOPUS electronic databases about the prevalence of HPV DNA in endometrial, primary fallopian tube, ovarian and primary peritoneal cancers, as well as uterine sarcomas. The present investigation covered 35 studies from different countries of various continents. Overall, HPV prevalence was approximately 15% in all the above cancers. HPV DNA was isolated from 11%, 0%, 0% and 14% of endometrial carcinomas, uterine sarcomas, primary fallopian tube cancers and ovarian malignant neoplasms, respectively. No relevant studies on primary peritoneal cancers were retrieved. The predominant HPV strain from all tumors of the upper female reproductive tract, regardless of the tumor site, was mostly HPV-16, followed by HPV-18. HPV DNA was identified exclusively from subtypes HPV-6, HPV-11, HPV-16, HPV-18, and HPV-33, which are responsible for the development of not only cervical cancer, but also of condylomata acuminata. The findings of the present review indicate that HPV vaccination might prove to be a useful strategy in the prevention HPV-related carcinomas of the upper genital tract in women.
- Open Access
- 1 March 2025
- Published by AME Publishing Company in Journal of Visualized Surgery
- Vol. 11, 5
Autologous pubovaginal fascial sling from external oblique muscle aponeurosis in the treatment of urodynamic stress urinary incontinence in women: a surgical technique
Surgical treatment of female stress urinary incontinence (SUI) has been performed for over a century. Various techniques have been utilized, with retropubic colposuspension and sling procedures being the most prevalent. Among sling methods, the use of synthetic midurethral slings (MUS) gained widespread acceptance due to their effectiveness and ease of placement, becoming the gold standard for many practitioners. However, concerns regarding intermediate and long-term complications, including erosion, chronic pain, and dyspareunia, as well as challenges in removal, have led to increased scrutiny and restrictions on their use. Regulatory concerns by the Food and Drug Administration (FDA) and Health Canada regarding vaginal mesh have prompted urogynecologists to seek alternative methods, including autologous fascial pubovaginal slings as a first or second-line option. This video article presents a novel surgical technique utilizing strips from the external oblique muscle aponeurosis for the treatment of SUI. The procedure is performed in four key steps: (I) harvesting an at least 10–12 cm long, 5–7 mm wide fascial strip from the external oblique muscle aponeurosis; (II) preparing the anterior vaginal wall and creating a small vertical incision; (III) placing the sling via the retropubic space using an introducer needle; and (IV) securing the fascial strip under the bladder neck with Prolene 3-0 sutures, ensuring appropriate tension to avoid obstruction and maintaining a distance of one finger breadth of the strip under the bladder neck. The average operative time is approximately 90 minutes. While autologous fascial slings require longer operative time and technical expertise, they offer a viable alternative with potentially lower long-term complications. Encouraging long-term outcomes support their role in SUI management, particularly in light of the restricted use of synthetic slings in several countries. Understanding the technique of autologous fascial slings is essential for surgeons to provide safe and effective treatment options for SUI.
- 1 March 2025
- Published by AME Publishing Company in Journal of Visualized Surgery
- Vol. 11, 5
Open AccessAutologous pubovaginal fascial sling from external oblique muscle aponeurosis in the treatment of urodynamic stress urinary incontinence in women: a surgical technique
Surgical treatment of female stress urinary incontinence (SUI) has been performed for over a century. Various techniques have been utilized, with retropubic colposuspension and sling procedures being the most prevalent. Among sling methods, the use of synthetic midurethral slings (MUS) gained widespread acceptance due to their effectiveness and ease of placement, becoming the gold standard for many practitioners. However, concerns regarding intermediate and long-term complications, including erosion, chronic pain, and dyspareunia, as well as challenges in removal, have led to increased scrutiny and restrictions on their use. Regulatory concerns by the Food and Drug Administration (FDA) and Health Canada regarding vaginal mesh have prompted urogynecologists to seek alternative methods, including autologous fascial pubovaginal slings as a first or second-line option. This video article presents a novel surgical technique utilizing strips from the external oblique muscle aponeurosis for the treatment of SUI. The procedure is performed in four key steps: (I) harvesting an at least 10–12 cm long, 5–7 mm wide fascial strip from the external oblique muscle aponeurosis; (II) preparing the anterior vaginal wall and creating a small vertical incision; (III) placing the sling via the retropubic space using an introducer needle; and (IV) securing the fascial strip under the bladder neck with Prolene 3-0 sutures, ensuring appropriate tension to avoid obstruction and maintaining a distance of one finger breadth of the strip under the bladder neck. The average operative time is approximately 90 minutes. While autologous fascial slings require longer operative time and technical expertise, they offer a viable alternative with potentially lower long-term complications. Encouraging long-term outcomes support their role in SUI management, particularly in light of the restricted use of synthetic slings in several countries. Understanding the technique of autologous fascial slings is essential for surgeons to provide safe and effective treatment options for SUI.
- Open Access
- 9 February 2023
- Published by Qeios Ltd
Review of: "Histopathological Patterns of Cervical Cancer Among Females Presenting to Makerere University Pathology Core Reference Laboratory. A 5-Year Review"
OVERALL EVALUATION ACCEPTANCE of this paper after _revision with minor changes _is suggested. COMMENTS TO THE AUTHORS * This is a quantative retrospective cross-sectional study. * The main research question is the distribution of the various...
- 9 February 2023
- Published by Qeios Ltd
Open AccessReview of: "Histopathological Patterns of Cervical Cancer Among Females Presenting to Makerere University Pathology Core Reference Laboratory. A 5-Year Review"
OVERALL EVALUATION ACCEPTANCE of this paper after _revision with minor changes _is suggested. COMMENTS TO THE AUTHORS * This is a quantative retrospective cross-sectional study. * The main research question is the distribution of the various...
- Open Access
- 1 December 2021
- Published by Walter de Gruyter GmbH in Forum of Clinical Oncology
- Vol. 12 (3) , 49-55
Clinicopathological characteristics in women with breast cancer in extreme ages in Greece: A single centre experience
Introduction: Breast cancer is the most common malignancy in Greek women. The highest incidence occurs in patients aged 40–70 years. However, the emergence of the disease in women under 40 and over 80 years old is a significant problem in everyday practice, because of the diagnostic and therapeutic challenges for these age groups. The objective of this study is to investigate clinicopathological characteristics of Greek women under 40 and over 80 diagnosed with breast cancer during 2019–2020 in a specialized Breast Cancer Surgical Centre, as well as the pathological characteristics of their disease and the therapeutic measures applied to these women. Aim of the study: The aim of this study is to compare clinical and pathological characteristics of breast cancer in a group of Greek premenopausal women younger than 40 years of age with a group of elderly women older than 80 years old, who were treated in a surgical breast centre in Greece during the last two years. Patients and Methods: During the last 2 years, 21 women under 40 and 22 women older than 80 were diagnosed with breast cancer in our Centre. Results: Invasive ductal adenocarcinoma was the most frequent histological type for both Groups: Most younger women underwent surgery followed by chemotherapy, while the majority of older patients received hormonal therapy after surgery. Conclusions: There were no statistically significant differences between women under 40 and women over 80 in the study sample regarding their clinicopathological characteristics. However, younger women underwent more therapeutic modalities (i.e.adjuvant treatments in addition to surgery) than older ones.
- 1 December 2021
- Published by Walter de Gruyter GmbH in Forum of Clinical Oncology
- Vol. 12 (3) , 49-55
Open AccessClinicopathological characteristics in women with breast cancer in extreme ages in Greece: A single centre experience
Introduction: Breast cancer is the most common malignancy in Greek women. The highest incidence occurs in patients aged 40–70 years. However, the emergence of the disease in women under 40 and over 80 years old is a significant problem in everyday practice, because of the diagnostic and therapeutic challenges for these age groups. The objective of this study is to investigate clinicopathological characteristics of Greek women under 40 and over 80 diagnosed with breast cancer during 2019–2020 in a specialized Breast Cancer Surgical Centre, as well as the pathological characteristics of their disease and the therapeutic measures applied to these women. Aim of the study: The aim of this study is to compare clinical and pathological characteristics of breast cancer in a group of Greek premenopausal women younger than 40 years of age with a group of elderly women older than 80 years old, who were treated in a surgical breast centre in Greece during the last two years. Patients and Methods: During the last 2 years, 21 women under 40 and 22 women older than 80 were diagnosed with breast cancer in our Centre. Results: Invasive ductal adenocarcinoma was the most frequent histological type for both Groups: Most younger women underwent surgery followed by chemotherapy, while the majority of older patients received hormonal therapy after surgery. Conclusions: There were no statistically significant differences between women under 40 and women over 80 in the study sample regarding their clinicopathological characteristics. However, younger women underwent more therapeutic modalities (i.e.adjuvant treatments in addition to surgery) than older ones.
- Open Access
- 1 October 2018
- Published by Elsevier in Case Reports in Women's Health
- Vol. 20, e00083
Postpartum nephrotic syndrome related to new onset of systemic lupus erythematosus: A case report
- 1 October 2018
- Published by Elsevier in Case Reports in Women's Health
- Vol. 20, e00083
Open AccessPostpartum nephrotic syndrome related to new onset of systemic lupus erythematosus: A case report
- 7 July 2018
- Published by Springer Nature in International Urogynecology Journal
- Vol. 30 (2) , 265-269
Assessment of the long-term outcome of TVT procedure for stress urinary incontinence in a female population: results at 17 years’ follow-up
To assess the outcome of the tension-free vaginal tape (TVT) procedure in female patients with urodynamic stress urinary incontinence at 17 years follow-up.
- 7 July 2018
- Published by Springer Nature in International Urogynecology Journal
- Vol. 30 (2) , 265-269
Assessment of the long-term outcome of TVT procedure for stress urinary incontinence in a female population: results at 17 years’ follow-up
To assess the outcome of the tension-free vaginal tape (TVT) procedure in female patients with urodynamic stress urinary incontinence at 17 years follow-up.